Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Prostasol and venous thromboembolism.

Clement J, Bubley G.

Urology. 2008 Sep;72(3):664-6. doi: 10.1016/j.urology.2008.04.045. Epub 2008 Jul 7.

PMID:
18602145
2.

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ.

J Clin Oncol. 2004 Sep 15;22(18):3705-12. Epub 2004 Aug 2.

PMID:
15289492
3.

Complementary and alternative therapies in prostate cancer.

Oh WK, Small EJ.

Semin Oncol. 2002 Dec;29(6):575-84. Review.

PMID:
12516040
4.

[PC-SPES and ProstaSol: Chinese herbal medicine as a treatment for prostate cancer].

Jensen JB, Langkilde NC.

Ugeskr Laeger. 2004 Dec 6;166(50):4611-2. Danish. No abstract available.

PMID:
15633553
5.

UsToo PC-SPES surveys: review of studies and update of previous survey results.

Porterfield H.

Mol Urol. 2000 Fall;4(3):289-91;discussion 293.

PMID:
11062386
6.

Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.

van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR.

Thromb Haemost. 2009 Apr;101(4):762-9.

PMID:
19350123
7.

Critical review of complementary therapies for prostate cancer.

Wilkinson S, Chodak GW.

J Clin Oncol. 2003 Jun 1;21(11):2199-210. Review.

PMID:
12775747
8.

PC-SPES for treatment of prostate cancer: herbal medicine.

Yip I, Cudiamat M, Chim D.

Curr Urol Rep. 2003 Jun;4(3):253-7. Review.

PMID:
12756091
9.
10.

The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.

Klotz L, Boccon-Gibod L, Shore ND, Andreou C, Persson BE, Cantor P, Jensen JK, Olesen TK, Schröder FH.

BJU Int. 2008 Dec;102(11):1531-8. doi: 10.1111/j.1464-410X.2008.08183.x.

11.

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study.

Sørensen HT, Horvath-Puho E, Søgaard KK, Christensen S, Johnsen SP, Thomsen RW, Prandoni P, Baron JA.

J Thromb Haemost. 2009 Apr;7(4):521-8. doi: 10.1111/j.1538-7836.2009.03279.x. Epub 2009 Jan 13.

12.

Complementary and alternative medicine in prostate cancer.

Jacobson JS, Chetty AP.

Curr Oncol Rep. 2001 Sep;3(5):448-52. Review.

PMID:
11489247
13.

PC-SPES--a lesson for future dietary supplement research.

White J.

J Natl Cancer Inst. 2002 Sep 4;94(17):1261-3. No abstract available.

PMID:
12208885
14.

A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.

Gittelman M, Pommerville PJ, Persson BE, Jensen JK, Olesen TK; Degarelix Study Group.

J Urol. 2008 Nov;180(5):1986-92. doi: 10.1016/j.juro.2008.07.033. Epub 2008 Sep 17.

PMID:
18801505
15.

Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.

Amin AN, Lin J, Lenhart G, Schulman KL.

Thromb Haemost. 2009 Aug;102(2):321-6. doi: 10.1160/TH09-03-0147.

PMID:
19652883
16.

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.

Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.

Am Heart J. 2009 Aug;158(2):252-6. doi: 10.1016/j.ahj.2009.06.005.

PMID:
19619702
17.

New agents in medical oncology and the risk of venous thromboembolism.

Manzoni M, Bencardino K, Piovella F, Chatzileontiadou S, Delfanti S, Riccardi A, Danova M, Corazza GR.

J Exp Clin Cancer Res. 2007 Jun;26(2):185-94. Review.

PMID:
17725097
18.
19.

Risk of venous thromboembolism with rheumatoid arthritis.

Matta F, Singala R, Yaekoub AY, Najjar R, Stein PD.

Thromb Haemost. 2009 Jan;101(1):134-8.

PMID:
19132199
20.

PC-SPES: hope or hype?

Kosty MP.

J Clin Oncol. 2004 Sep 15;22(18):3657-9. Epub 2004 Aug 2. No abstract available.

PMID:
15289490

Supplemental Content

Support Center